Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
Status:
Unknown status
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if of combination therapy of intravitreal
bevacizumab 4 days after the application of photodynamic therapy could improve the visual
outcomes of patients with neovascular age related macular degeneration.